News

Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.
Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle ...
Continuous Glucose Monitoring (CGM) devices make it easy to keep your health in check despite seasonal changes, without the ...
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX ...
Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings. They should maintain their dividend growth habits ...
Two experts discuss why more research is needed before continuous glucose monitors can be used reliably for insulin ...
Thanh Thuy, an employee at Abbott Vietnam, experienced the company's upgraded mixed reality technology at a blood donation event in downtown Hanoi.
Abbott and Beta Bionics are collaborating to integrate Abbott’s upcoming dual glucose-ketone sensor with Beta’s iLet Bionic ...
For people with type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...
MIT’s wireless skin implant delivers glucagon instantly when blood sugar drops, offering new safety for diabetics, even while ...
Mattel has introduced its first Barbie doll with representing someone with Type 1 diabetes. The doll, part of the ...
Small, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...